You are here

Lixoft

Lixoft develops modeling and simulation software for advanced model-based drug development. Lixoft creates innovating tools for model-based drug development, fit for pharma & biotech companies, CROs, and for extensive deployment in any pharmaceutical workflow, from preclinical studies to final submission.

Monolix® is Lixoft's flagship product. Monolix allows the use of the most complex models in pharmacometrics. It offers a powerful, fast and easy solution for population analysis in mixed models in pre-clinical and clinical trials.

Lixoft's technologies are the result of a ten years research program in statistics and modeling, led by INRIA on non-linear mixed effect models for advanced population analysis, PK/PD, pre-clinical and clinical trial modeling & simulation.

 

Country: 
France

Associated members

SMEs
Jerome Kalifa's picture
Jerome Kalifa
Lixoft